STOCKHOLDERS’ EQUITY |
9 Months Ended |
|---|---|
Dec. 31, 2025 | |
| Statement of Stockholders' Equity [Abstract] | |
| STOCKHOLDERS’ EQUITY | STOCKHOLDERS’ EQUITY On August 17, 2023, June 3, 2024, and February 26, 2025, the Company respectively announced that its Board of Directors (the “Board”) had authorized a stock repurchase program, pursuant to which the Company was authorized to repurchase, from time to time, up to an aggregate of $7.5 million, $15.0 million, and $4.0 million or $26.5 million in total, of the Company’s outstanding shares of common stock, exclusive of any fees, commissions or other expenses related to such repurchases, in open market transactions made in accordance with the provisions of Rule 10b-18 and/or Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, privately negotiated transactions or by other means in accordance with applicable securities laws. During the three months ended December 31, 2025 the Company did not repurchase any shares of common stock. During the nine months ended December 31, 2025, the Company repurchased a total of 1,310,627 shares of its common stock under the program for $1.8 million at an average price of $1.35. During the three and nine months ended December 31, 2024, the Company repurchased a total of 1,682,671 and 5,225,531 shares of its common stock under the program for $2.8 million and $8.0 million at an average price of $1.69 and $1.54, respectively. The repurchased shares of common stock were recorded as treasury stock and were accounted for under the cost method. None of the repurchased shares of common stock have been retired. As of December 31, 2025, none of the shares authorized for issuance under the two stock repurchase programs remained available for future share repurchases. |